Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy | Zendy

Rossana Berardi | Zendy; Silvia Rinaldi | Zendy; Matteo Santoni | Zendy; Thomas Newsom-Davis | Zendy; Michela Tiberi | Zendy; Francesca Morgese | Zendy; Miriam Caramanti | Zendy; Agnese Savini | Zendy; Consuelo Ferrini | Zendy; Mariangela Torniai | Zendy; Ilaria Fiordoliva | Zendy; Mark Bower | Zendy; Stefano Cascinu | Zendy

Open Access

Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy

Author(s) -

Rossana Berardi,

Silvia Rinaldi,

Matteo Santoni,

Thomas Newsom-Davis,

Michela Tiberi,

Francesca Morgese,

Miriam Caramanti,

Agnese Savini,

Consuelo Ferrini,

Mariangela Torniai,

Ilaria Fiordoliva,

Mark Bower,

Stefano Cascinu

Publication year - 2016

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.8309

Subject(s) - medicine , lung cancer , neutrophil to lymphocyte ratio , oncology , performance status , cancer , lymphocytopenia , proportional hazards model , gastroenterology , stage (stratigraphy) , adenocarcinoma , multivariate analysis , overall survival , lymphocyte , paleontology , biology

We aimed to assess the prognostic role of neutrophilia, lymphocytopenia and the neutrophil-to-lymphocyte ratio (NLR), and to design models to define the prognosis of patients receiving first-line chemo- or targeted therapy for advanced non-small cell lung cancer (NSCLC).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research